Reported 2 days ago
Healthcare and biotech stocks are showing signs of recovery in 2025 after a long period of underperformance compared to the broader market. Yahoo Finance's Jared Blikre discusses the potential for these stocks to catch up, noting that after significant outflows, the current market conditions might incentivize investors to re-enter the sector. Despite the risks, the low beta and historical performance during midterm elections also offer a case for considering healthcare investments as part of a diversified portfolio.
Source: YAHOO